Zhitong Finance App News, Corning Jerry Pharmaceutical-B (09966.HK) issued an announcement. The US Food and Drug Administration (FDA) has approved JSKN021 (a bispecific antibody double load coupling drug (ADC (s))) independently developed by the company and targeting epidermal growth factor receptor (EGFR) /human epidermal growth factor receptor 3 (HER3)) to conduct phase I clinical research (study number: JSKN021-101), a new drug clinical trial application (IND) for overseas clinical development of JSKN021 Officially launched.

Zhitong Finance App News, Corning Jerry Pharmaceutical-B (09966.HK) issued an announcement. The US Food and Drug Administration (FDA) has approved JSKN021 (a bispecific antibody double load coupling drug (ADC (s))) independently developed by the company and targeting epidermal growth factor receptor (EGFR) /human epidermal growth factor receptor 3 (HER3)) to conduct phase I clinical research (study number: JSKN021-101), a new drug clinical trial application (IND) for overseas clinical development of JSKN021 Officially launched.